The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Urocheck     2,3,5-triphenyl-1,3,4-triaza- 2...

Synonyms: Uroscreen, Vitastain, Tetrazole Red, PubChem9166, ARONIS24963, ...
This record was replaced with 9284.
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.



Psychiatry related information on TRIPHENYLTETRAZOLIUM CHLORIDE



  • GPI 562 exhibited a dose-dependent reduction of cerebral infarct volumes measured by triphenyltetrazolium chloride staining, as well as improvement in postischemic cerebral blood flow, measured by laser doppler [7].
  • Mice immunodepleted of neutrophils before surgery demonstrated a 3.0-fold reduction in infarct volumes (P < 0.001), based on triphenyltetrazolium chloride staining of serial cerebral sections, improved ipsilateral cortical cerebral blood flow (measured by laser Doppler), and reduced neurological deficit compared with controls [8].
  • Fluorescent Boc-FLFLF did not elicit an oxidative burst in the neutrophil at 37 degrees C, as assessed by chemiluminescence and reduction of p-nitroblue tetrazolium chloride, but competed efficiently both with formyl-methionyl-leucyl-phenylalanine (fMLF) and fnLLFnLYK [9].
  • The myocardial infarct size/ischemic area at risk and the count of presumed apoptotic cardiomyocytes (terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling [TUNEL]-positive cells) within the ischemic area at risk were assessed through triphenyltetrazolium chloride staining and TUNEL methods, respectively [10].
  • METHODS AND RESULTS: In 71 enflurane-anesthetized swine, severe left anterior descending coronary artery hypoperfusion for 90 minutes followed by 2 hours of reperfusion resulted in an infarct size (IS, by triphenyltetrazolium chloride) of 16.7+/-3.4% (SEM) of the area at risk [11].

Chemical compound and disease context of TRIPHENYLTETRAZOLIUM CHLORIDE






Associations of TRIPHENYLTETRAZOLIUM CHLORIDE with other chemical compounds




Analytical, diagnostic and therapeutic context of TRIPHENYLTETRAZOLIUM CHLORIDE


  1. A comparison of quantitative echocardiographic methods for delineating infarct-induced abnormal wall motion. Gillam, L.D., Hogan, R.D., Foale, R.A., Franklin, T.D., Newell, J.B., Guyer, D.E., Weyman, A.E. Circulation (1984) [Pubmed]
  2. Receptor-mediated cardioprotective effects of endogenous adenosine are exerted primarily during reperfusion after coronary occlusion in the rabbit. Zhao, Z.Q., McGee, S., Nakanishi, K., Toombs, C.F., Johnston, W.E., Ashar, M.S., Vinten-Johansen, J. Circulation (1993) [Pubmed]
  3. Quantification of myocardial injury produced by temporary coronary artery occlusion and reflow with technetium-99m-pyrophosphate. Jansen, D.E., Corbett, J.R., Buja, L.M., Hansen, C., Ugolini, V., Parkey, R.W., Willerson, J.T. Circulation (1987) [Pubmed]
  4. Effect of a critical coronary stenosis on myocardial neutrophil accumulation during ischemia and early reperfusion in dogs. Richard, V.J., Brooks, S.E., Jennings, R.B., Reimer, K.A. Circulation (1989) [Pubmed]
  5. Protective effect of exogenous administration of alpha-tocopherol in middle cerebral artery occlusion model of cerebral ischemia in rats. Chaudhary, G., Sinha, K., Gupta, Y.K. Fundamental & clinical pharmacology. (2003) [Pubmed]
  6. Mild Brain Ischemia Produces Bladder Hyperactivity without Brain Damage in Rats. Yotsuyanagi, S., Narimoto, K., Namiki, M. Urologia internationalis. (2006) [Pubmed]
  7. Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation. Choudhri, T.F., Hoh, B.L., Zerwes, H.G., Prestigiacomo, C.J., Kim, S.C., Connolly, E.S., Kottirsch, G., Pinsky, D.J. J. Clin. Invest. (1998) [Pubmed]
  8. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. Connolly, E.S., Winfree, C.J., Springer, T.A., Naka, Y., Liao, H., Yan, S.D., Stern, D.M., Solomon, R.A., Gutierrez-Ramos, J.C., Pinsky, D.J. J. Clin. Invest. (1996) [Pubmed]
  9. N-formyl peptide receptors in human neutrophils display distinct membrane distribution and lateral mobility when labeled with agonist and antagonist. Johansson, B., Wymann, M.P., Holmgren-Peterson, K., Magnusson, K.E. J. Cell Biol. (1993) [Pubmed]
  10. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Yaoita, H., Ogawa, K., Maehara, K., Maruyama, Y. Circulation (1998) [Pubmed]
  11. Ischemic preconditioning in pigs: a graded phenomenon: its relation to adenosine and bradykinin. Schulz, R., Post, H., Vahlhaus, C., Heusch, G. Circulation (1998) [Pubmed]
  12. Coronary thrombolysis with recombinant human tissue-type plasminogen activator. Gold, H.K., Fallon, J.T., Yasuda, T., Leinbach, R.C., Khaw, B.A., Newell, J.B., Guerrero, J.L., Vislosky, F.M., Hoyng, C.F., Grossbard, E. Circulation (1984) [Pubmed]
  13. Increased infarct size in uremic rats: reduced ischemia tolerance? Dikow, R., Kihm, L.P., Zeier, M., Kapitza, J., Törnig, J., Amann, K., Tiefenbacher, C., Ritz, E. J. Am. Soc. Nephrol. (2004) [Pubmed]
  14. Prostaglandin E1 coronary venous retroperfusion in acute myocardial ischemia: effects on regional left ventricular function and infarct size. Povzhitkov, M., Haendchen, R.V., Meerbaum, S., Fishbein, M.C., Shell, W., Corday, E. J. Am. Coll. Cardiol. (1984) [Pubmed]
  15. A comparison of intra-arterial and intravenous tissue-type plasminogen activator on autologous arterial emboli in the cerebral circulation of rabbits. Hamilton, M.G., Lee, J.S., Cummings, P.J., Zabramski, J.M. Stroke (1994) [Pubmed]
  16. Evaluation of 2,3,5-triphenyltetrazolium chloride staining to delineate rat brain infarcts. Isayama, K., Pitts, L.H., Nishimura, M.C. Stroke (1991) [Pubmed]
  17. No reflow and extent of infarction during maximal vasodilation in the porcine heart. Johnson, W.B., Malone, S.A., Pantely, G.A., Anselone, C.G., Bristow, J.D. Circulation (1988) [Pubmed]
  18. Ineffective perfusion-contraction matching in conscious, chronically instrumented pigs with an extended period of coronary stenosis. Kudej, R.K., Ghaleh, B., Sato, N., Shen, Y.T., Bishop, S.P., Vatner, S.F. Circ. Res. (1998) [Pubmed]
  19. Endogenous nitric oxide and myocardial adaptation to ischemia. Heusch, G., Post, H., Michel, M.C., Kelm, M., Schulz, R. Circ. Res. (2000) [Pubmed]
  20. Calpain and mitochondria in ischemia/reperfusion injury. Chen, M., Won, D.J., Krajewski, S., Gottlieb, R.A. J. Biol. Chem. (2002) [Pubmed]
  21. Evaluation of source leaf responses to water-deficit stresses in cotton using a novel stress bioassay. Burke, J.J. Plant Physiol. (2007) [Pubmed]
  22. Studies of amiodarone during experimental myocardial infarction: beneficial effects on hemodynamics and infarct size. DeBoer, L.W., Nosta, J.J., Kloner, R.A., Braunwald, E. Circulation (1982) [Pubmed]
  23. The relationship of vascular injury and myocardial hemorrhage to necrosis after reperfusion. Fishbein, M.C., Y-Rit, J., Lando, U., Kanmatsuse, K., Mercier, J.C., Ganz, W. Circulation (1980) [Pubmed]
  24. The cardioprotective effects of ischemic 'preconditioning' are not mediated by adenosine receptors in rat hearts. Li, Y., Kloner, R.A. Circulation (1993) [Pubmed]
  25. Infarct salvage with liposomal prostaglandin E1 administered by intravenous bolus immediately before reperfusion in a canine infarction-reperfusion model. Smalling, R.W., Feld, S., Ramanna, N., Amirian, J., Felli, P., Vaughn, W.K., Swenson, C., Janoff, A. Circulation (1995) [Pubmed]
  26. Does reperfusion extend necrosis? A study in a single territory of myocardial ischemia--half reperfused and half not reperfused. Ganz, W., Watanabe, I., Kanamasa, K., Yano, J., Han, D.S., Fishbein, M.C. Circulation (1990) [Pubmed]
  27. Quantification of experimental myocardial infarction using nuclear magnetic resonance imaging and paramagnetic ion contrast enhancement in excised canine hearts. Goldman, M.R., Brady, T.J., Pykett, I.L., Burt, C.T., Buonanno, F.S., Kistler, J.P., Newhouse, J.H., Hinshaw, W.S., Pohost, G.M. Circulation (1982) [Pubmed]
  28. Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias. Harada, K., Komuro, I., Hayashi, D., Sugaya, T., Murakami, K., Yazaki, Y. Circulation (1998) [Pubmed]
  29. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Rochitte, C.E., Lima, J.A., Bluemke, D.A., Reeder, S.B., McVeigh, E.R., Furuta, T., Becker, L.C., Melin, J.A. Circulation (1998) [Pubmed]
  30. Assessment of risk area during coronary occlusion and infarct size after reperfusion with myocardial contrast echocardiography using left and right atrial injections of contrast. Villanueva, F.S., Glasheen, W.P., Sklenar, J., Kaul, S. Circulation (1993) [Pubmed]
  31. High-speed MR imaging of ischemic brain injury following stenosis of the middle cerebral artery. Roberts, T.P., Vexler, Z., Derugin, N., Moseley, M.E., Kucharczyk, J. J. Cereb. Blood Flow Metab. (1993) [Pubmed]
  32. Attenuation of focal ischemic brain injury in mice deficient in the epsilon1 (NR2A) subunit of NMDA receptor. Morikawa, E., Mori, H., Kiyama, Y., Mishina, M., Asano, T., Kirino, T. J. Neurosci. (1998) [Pubmed]
  33. Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects. Smith, C.C., Mocanu, M.M., Davidson, S.M., Wynne, A.M., Simpkin, J.C., Yellon, D.M. Br. J. Pharmacol. (2006) [Pubmed]
  34. Genetic deletion of fas receptors or Fas ligands does not reduce infarct size after acute global ischemia-reperfusion in isolated mouse heart. Tekin, D., Xi, L., Kukreja, R.C. Cell Biochem. Biophys. (2006) [Pubmed]
  35. Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway. Bell, R.M., Yellon, D.M. J. Am. Coll. Cardiol. (2003) [Pubmed]
  36. Transplantation of fetal kidney tissue reduces cerebral infarction induced by middle cerebral artery ligation. Chiang, Y.H., Lin, S.Z., Borlongan, C.V., Hoffer, B.J., Morales, M., Wang, Y. J. Cereb. Blood Flow Metab. (1999) [Pubmed]
  37. Fostriecin, an inhibitor of protein phosphatase 2A, limits myocardial infarct size even when administered after onset of ischemia. Weinbrenner, C., Baines, C.P., Liu, G.S., Armstrong, S.C., Ganote, C.E., Walsh, A.H., Honkanen, R.E., Cohen, M.V., Downey, J.M. Circulation (1998) [Pubmed]
  38. Catalase inhibition with 3-amino-1,2,4-triazole does not abolish infarct size reduction in heat-shocked rats. Auyeung, Y., Sievers, R.E., Weng, D., Barbosa, V., Wolfe, C.L. Circulation (1995) [Pubmed]
  39. Progression of myocardial necrosis during reperfusion of ischemic myocardium. Matsumura, K., Jeremy, R.W., Schaper, J., Becker, L.C. Circulation (1998) [Pubmed]
  40. The effect of left atrial-to-aortic assistance on infarct size. Laks, H., Ott, R.A., Standeven, J.W., Hahn, J.W., Blair, O.M., Willman, V.L. Circulation (1977) [Pubmed]
  41. Hydrogen peroxide contrast echocardiography: quantification in vivo of myocardial risk area during coronary occlusion and of the necrotic area remaining after myocardial reperfusion. Kemper, A.J., O'Boyle, J.E., Cohen, C.A., Taylor, A., Parisi, A.F. Circulation (1984) [Pubmed]
WikiGenes - Universities